Literature DB >> 17318454

Clinical characterization and risk profile of individuals seeking genetic counseling for hereditary breast cancer in Brazil.

Edenir Inez Palmero1, Patricia Ashton-Prolla, José Cláudio C da Rocha, Fernando Regla Vargas, Luciane Kalakun, Melissa Brauner Blom, Sérgio J Azevedo, Maira Caleffi, Roberto Giugliani, Lavinia Schüler-Faccini.   

Abstract

Hereditary breast cancer (HBC) accounts for 5-10% of breast cancer cases and it significantly increases the lifetime risk of cancer. Our objective was to evaluate the sociodemographic variables, family history of cancer, breast cancer (BC) screening practices and the risk profile of cancer affected or asymptomatic at-risk women that undergo genetic counseling for hereditary breast cancer in public Brazilian cancer genetics services. Estimated lifetime risk of BC was calculated for asymptomatic women using the Gail and Claus models. The majority of women showed a moderate lifetime risk of developing BC, with an average risk of 19.7% and 19.9% by the Gail and Claus models, respectively. The average prior probability of carrying a BRCA1/2 gene mutation was 16.7% and overall only 32% fulfilled criteria for a hereditary breast cancer syndrome as assessed by family history. We conclude that a significant number of individuals at high-risk for HBC syndromes may not have access to the benefits of cancer genetic counseling in these centers. Contributing factors may include insufficient training of healthcare professionals, disinformation of cancer patients; difficult access to genetic testing and/or resistance in seeking such services. The identification and understanding of these barriers is essential to develop specific strategies to effectively achieve cancer risk reduction in this and other countries were clinical cancer genetics is not yet fully established.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318454     DOI: 10.1007/s10897-006-9073-0

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.717


  28 in total

1.  Population risk, actual risk, perceived risk, and cancer control: a discussion.

Authors:  H Leventhal; K Kelly; E A Leventhal
Journal:  J Natl Cancer Inst Monogr       Date:  1999

2.  Cowden Syndrome.

Authors:  C Eng
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

3.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

4.  Recruiting high risk women into a breast cancer health promotion trial.

Authors:  C Lerman; B K Rimer; M Daly; E Lustbader; C Sands; A Balshem; A Masny; P Engstrom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Apr-May       Impact factor: 4.254

Review 5.  Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.

Authors:  A Eisen; T R Rebbeck; W C Wood; B L Weber
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

6.  Cancer genetics clinics: target population and consultees' expectations.

Authors:  C Julian-Reynier; F Eisinger; F Chabal; Y Aurran; C Noguès; P Vennin; Y J Bignon; M Machelard-Roumagnac; C Maugard-Louboutin; D Serin; S Versini; M Mercuri; H Sobol
Journal:  Eur J Cancer       Date:  1996-03       Impact factor: 9.162

7.  Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

Authors:  J M Birch; A L Hartley; K J Tricker; J Prosser; A Condie; A M Kelsey; M Harris; P H Jones; A Binchy; D Crowther
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

8.  Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

Authors:  T S Frank; S A Manley; O I Olopade; S Cummings; J E Garber; B Bernhardt; K Antman; D Russo; M E Wood; L Mullineau; C Isaacs; B Peshkin; S Buys; V Venne; P T Rowley; S Loader; K Offit; M Robson; H Hampel; D Brener; E P Winer; S Clark; B Weber; L C Strong; A Thomas
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544

9.  A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics.

Authors:  D Wonderling; P Hopwood; A Cull; F Douglas; M Watson; J Burn; K McPherson
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

10.  Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.

Authors:  H Sobol; Y J Bignon; C Bonaiti; J Cuisenier; C Lasset; A Lortholary; C Noguès; D Stoppa-Lyonnet; F Eisinger
Journal:  Dis Markers       Date:  1999-10       Impact factor: 3.434

View more
  14 in total

1.  Effects of a genetic counseling model on mothers of children with down syndrome: a Brazilian pilot study.

Authors:  Marcos Ricardo Datti Micheletto; Nelson Iguimar Valerio; Agnes Cristina Fett-Conte
Journal:  J Genet Couns       Date:  2013-06-23       Impact factor: 2.537

2.  Epigenetic transgenerational actions of endocrine disruptors.

Authors:  Michael K Skinner; Mohan Manikkam; Carlos Guerrero-Bosagna
Journal:  Reprod Toxicol       Date:  2010-11-03       Impact factor: 3.143

3.  Knowledge about hereditary cancer of women with family histories of breast, colorectal, or both types of cancer.

Authors:  N Campacci; J O de Lima; L Ramadan; E I Palmero
Journal:  J Cancer Educ       Date:  2015-03       Impact factor: 2.037

4.  Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study.

Authors:  Sook-Yee Yoon; Meow-Keong Thong; Nur Aishah Mohd Taib; Cheng-Har Yip; Soo-Hwang Teo
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

Review 5.  Inequities in genetic testing for hereditary breast cancer: implications for public health practice.

Authors:  Ambreen Sayani
Journal:  J Community Genet       Date:  2018-05-20

Review 6.  A systematic review of factors that act as barriers to patient referral to genetic services.

Authors:  Türem Delikurt; Graham R Williamson; Violetta Anastasiadou; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2014-09-10       Impact factor: 4.246

Review 7.  Clinical Cancer Genetics Disparities among Latinos.

Authors:  Marcia Cruz-Correa; Julyann Pérez-Mayoral; Julie Dutil; Miguel Echenique; Rafael Mosquera; Keila Rivera-Román; Sharee Umpierre; Segundo Rodriguez-Quilichini; Maria Gonzalez-Pons; Myrta I Olivera; Sherly Pardo
Journal:  J Genet Couns       Date:  2016-12-12       Impact factor: 2.537

8.  Histological profile and age at diagnosis of breast and ovarian tumors: A register-based study in Espirito Santo, Brazil.

Authors:  Eldamária DE Vargas Wolfgramm; Camila Fátima Biancardi Gavioli; Mayara Lemos Entringer; Lyvia Neves Rebello Alves; Elaine Stur; Allan Kardec DE Castro Neto; Luciene Lage DA Motta; Fausto Edmundo Lima Pereira; Iuri Drumond Louro
Journal:  Mol Clin Oncol       Date:  2012-11-05

9.  Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil.

Authors:  Edenir I Palmero; Maira Caleffi; Lavínia Schüler-Faccini; Fernanda L Roth; Luciane Kalakun; Cristina Brinkmann Oliveira Netto; Giovana Skonieski; Juliana Giacomazzi; Bernadete Weber; Roberto Giugliani; Suzi A Camey; Patricia Ashton-Prolla
Journal:  Genet Mol Biol       Date:  2009-09-01       Impact factor: 1.771

10.  Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.

Authors:  Patricia Ashton-Prolla; Juliana Giacomazzi; Aishameriane V Schmidt; Fernanda L Roth; Edenir I Palmero; Luciane Kalakun; Ernestina S Aguiar; Susana M Moreira; Erica Batassini; Vanessa Belo-Reyes; Lavinia Schuler-Faccini; Roberto Giugliani; Maira Caleffi; Suzi Alves Camey
Journal:  BMC Cancer       Date:  2009-08-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.